Decoding fibrosis: Mechanisms and translational aspects

Area of Science:

• Biomedical Research
• Translational Medicine
• Pathology

Background:

• Fibrosis, a pathological tissue healing process, leads to organ dysfunction and is a major global cause of mortality.
• Current antifibrotic strategies are largely restricted to organ transplantation, highlighting an unmet clinical need.
• Significant advancements in understanding fibrogenesis have been made over the past two decades.

Discussion:

• Novel fibrogenic factors and biomarkers have been identified, advancing diagnostic capabilities.
• Development of noninvasive diagnostic methods and targeted drug delivery systems are crucial for fibrosis management.
• Ongoing clinical trials are investigating organ-specific and stage-specific antifibrotic mechanisms.

Key Insights:

• Identification of new fibrogenic factors and biomarkers.
• Advancements in noninvasive diagnostics and drug delivery systems for fibrosis.
• Progress in clinical trials targeting diverse fibrotic conditions.

Outlook:

• Critically evaluating past and present therapeutic strategies for fibrosis.
• Potential for novel, effective antifibrotic treatments across various organ systems.
• Translational research bridging basic science and clinical application to combat organ fibrosis.